EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.
Issue link: https://digital.eyeworld.org/i/892879
World view Dive into dry eye disease Clara Chan, MD, Cornea editor The official publication of the American Society of Cataract & Refractive Surgery A S C R S November 2017 Vol. 22 • No. 11 Publisher Donald Long don@eyeworld.org Editorial Editor Amy Goldenberg amy@eyeworld.org Managing Editor Stacy Jablonski stacy@eyeworld.org Senior Staff Writer/Digital Editor Ellen Stodola ellen@eyeworld.org Staff Writer Liz Hillman liz@eyeworld.org Production Graphic Designer Julio Guerrero julio@eyeworld.org Graphic Design Assistant Susan Steury susan@eyeworld.org Production Manager Cathy Stern cathy@eyeworld.org Production Assistant Carly Peterson carly@eyeworld.org Contributing Writers Stefanie Petrou Binder, MD Berlin, Germany Vanessa Caceres Bradenton, Florida Rich Daly Arlington, Virginia Lauren Lipuma Washington, D.C. Michelle Stephenson Roanoke, Virginia Senior Contributing Writer Maxine Lipner Nyack, New York Advertising Sales ASCRSMedia 4000 Legato Road Suite 700 Fairfax, VA 22033 703-591-2220 Fax: 703-591-0614 eyeworld@eyeworld.org www.eyeworld.org Paul Zelin paul@eyeworld.org Monica Frishman monica@eyeworld.org Classified Sales Cathy Stern cathy@eyeworld.org EyeWorld Special Projects and Events Jessica Donohoe jessica@eyeworld.org Shelly Dixon shelly@eyeworld.org Anne Le anne@eyeworld.org ASCRS Publisher: EyeWorld (ISSN 1089-0084) is published monthly by ASCRS Ophthalmic Services Corp., 4000 Legato Road, Suite 700, Fairfax, VA 22033-4055; telephone: 703-591-2220; fax: 703-591-0614. Printed in the U.S. Editorial Offices: EyeWorld News Service, 4000 Legato Road, Suite 700, Fairfax, VA 22033-4055; toll-free: 800-451-1339, 703-591-2220; fax: 703-591-0614; email: eyeworld@eyeworld.org. Advertising Offices: ASCRSMedia, 4000 Legato Road, Suite 700, Fairfax, VA 22033-4055; toll-free: 800-451-1339, 703-591-2220; fax: 703-591-0614; email: eyeworld@eyeworld.org. Copyright 2017, ASCRS Ophthalmic Services Corp., 4000 Legato Road, Suite 700, Fairfax, VA 22033-4055. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. Letters to the editor and other unsolicited material are assumed intended for publication and are subject to editorial review and acceptance. Subscriptions: Requests should be addressed to the publisher. Annual subscription prices: Individual: 1 year, $120; 2 years, $220; 3 years, $320. Institutional: 1 year, $250; 2 years, $330; 3 years, $425. Foreign: 1 year, $240, 2 years $470, 3 years, $700. Back copies: Subject to availability. Contact the publisher. Cost per copy is $15; $30 foreign. All orders for individual or back copies must be accompanied by payment. Requests to reprint, use, or republish: Requests to reprint or use material published herein should be made in writing only to Cathy Stern, EyeWorld, 4000 Legato Road, Suite 700, Fairfax, VA 22033-4055; toll-free: 800-451-1339, 703-591-2220; fax: 703-591-0614; email: eyeworld@eyeworld.org. EyeWorld reprints: To order reprints of material published in EyeWorld, contact Cathy Stern, EyeWorld, 4000 Legato Road, Suite 700, Fairfax, VA 22033-4055; toll-free: 800-451-1339, 703-591-2220; fax: 703-591-0614; email: cathy@eyeworld.org or your salesperson. Change of address: Notice should be sent to the publisher six weeks in advance of effective date. Include old and new addresses and label from recent issue. The publisher cannot accept responsibility for undelivered copies. POSTMASTER: Send change of address to EyeWorld, 4000 Legato Road, Suite 700, Fairfax, VA 22033. Periodical postage paid at Fairfax, VA 22033 and at additional mailing offices. The ideas and opinions expressed in EyeWorld do not necessarily reflect those of the editors, publisher, or its advertisers. P U B L I S H I N G S T A F F D ry eye disease can go untreated in many patients, so it's important to stay up to date on this condition. Based on multiple studies, the estimated prev- alence of dry eye ranges from 5% to 30% among those older than 50 years. There are now questionnaires, diagnostic tests, imaging modalities, and new therapies available to help diagnose and manage our dry eye patients. This is especially key to help patients achieve the best refractive outcomes in cataract and refractive surgery. In this issue of EyeWorld, Elizabeth Yeu, MD, David Glasser, MD, and Richard Davidson, MD, discuss how to best iden- tify patients with dry eye disease prior to cataract surgery, which features on slit lamp examination other than corneal fluorescein staining can influence the tear film quality, how to optimally treat the ocular surface and irregular tear film preoperatively, how to improve any meibomian gland dysfunction present, and how to identify which patients may not be candidates for ad- vanced technology intraocular lenses. Vatinee Bunya, MD, Anat Galor, MD, Christopher Rapuano, MD, and John Sheppard, MD, share the strategies they use to help diagnose dry eye, which diagnostic tests fit best in their practices, and the benefits to incorpo- rating advanced imaging techniques to counsel patients. Preeya Gupta, MD, Kazuo Tsubota, MD, and Vincent de Luise, MD, review the currently available medical, nutritional, and device-related treat- ment options for dry eye disease and what medications are coming down the pipeline. It is an exciting time as there are a larger number of options available and under development targeting aqueous tear deficiency, meibo- mian gland deficiency, neural pathways of dry eye, and conjunctival goblet cell health, to name a few. For those wanting an up-to-date, evidence-based framework on how to diagnose and manage dry eye patients, the latest reports from the Tear Film & Ocular Surface Society International Dry Eye WorkShop were recent- ly published in the journal The Ocular Surface. Anat Galor, MD, J. Daniel Nelson, MD, Esen Akpek, MD, Christopher Starr, MD, Preeya Gupta, MD, and David Sullivan, PhD, were members of various subcommittees that put together the reports. They share pearls on how to best read the lengthy docu- ment, highlight the key changes to the 2007 version—especially as related to the definition and classification of dry eye—and give recommendations on how to apply the knowledge to clinical practice. I hope you enjoy this issue of EyeWorld, and thank you to all the physi- cians for taking the time to share their expertise. EW Like us on Facebook facebook.com/EyeWorldMagazine Follow EyeWorld on Twitter twitter.com/EWNews Find us on social media